Fusen Pharmaceutical Co., Ltd. (HK:1652) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Fusen Pharmaceutical Company Limited is poised to hold a Board meeting on August 29, 2024, to discuss and potentially approve its subsidiaries’ unaudited interim financial results for the first half of the year ending June 30, 2024. The meeting will also consider the possibility of announcing an interim dividend. This announcement comes ahead of the meeting, indicating significant upcoming decisions that could impact the company’s financial direction.
For further insights into HK:1652 stock, check out TipRanks’ Stock Analysis page.